Escolà-Vergé, Laura
Pigrau, Carles
Los-Arcos, Ibai
Arévalo, Ángel
Viñado, Belen
Campany, David
Larrosa, Nieves
Nuvials, Xavier
Ferrer, Ricard
Len, Oscar
Almirante, Benito
Funding for this research was provided by:
Instituto de Salud Carlos III (REIPI RD16/0016/0003)
Article History
Received: 29 January 2018
Accepted: 16 March 2018
First Online: 28 March 2018
Compliance with ethical standards
:
: CP. has received honoraria for talks on behalf of Angelini, MSD, Novartis, Pfizer, Salvat, and Zambon. O.L. has received honoraria for talks on behalf of Astellas, MSD and Pfizer. R.F. has received honoraria for talks on behalf of MSD, Pfizer, Estor and Orion. B.A. has received grant support from Gilead Sciences, Pfizer, and the Instituto de Salud Carlos III. He has received honoraria for talks on behalf of Gilead Sciences, Merck Sharp & Dohme, Pfizer, Astellas Pharma, Novartis, and Angelini. The other authors have no declarations.